These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 30213806)
1. CT versus MR Imaging in Estimating Cochlear Radiation Dose during Gamma Knife Surgery for Vestibular Schwannomas. Faramand AM; Kano H; Johnson S; Niranjan A; Flickinger JC; Lunsford LD AJNR Am J Neuroradiol; 2018 Oct; 39(10):1907-1911. PubMed ID: 30213806 [TBL] [Abstract][Full Text] [Related]
2. Gamma knife radiosurgery for vestibular schwannoma: early hearing outcomes and evaluation of the cochlear dose. Lasak JM; Klish D; Kryzer TC; Hearn C; Gorecki JP; Rine GP Otol Neurotol; 2008 Dec; 29(8):1179-86. PubMed ID: 18931646 [TBL] [Abstract][Full Text] [Related]
3. Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Timmer FC; Hanssens PE; van Haren AE; Mulder JJ; Cremers CW; Beynon AJ; van Overbeeke JJ; Graamans K Laryngoscope; 2009 Jun; 119(6):1076-81. PubMed ID: 19399836 [TBL] [Abstract][Full Text] [Related]
4. Dosimetric Analysis of Neural and Vascular Structures in Skull Base Tumors Treated with Stereotactic Radiosurgery. Haidar YM; Bhatt JM; Ghavami Y; Moshtaghi O; Schwer A; Chenery S; Djalilian HR Otolaryngol Head Neck Surg; 2017 May; 156(5):857-862. PubMed ID: 28195750 [TBL] [Abstract][Full Text] [Related]
5. Radiosurgery of vestibular schwannoma: prognostic factors for hearing outcome using 3D-constructive interference in steady state (3D-CISS). Wagner F; Gandalini M; Hakim A; Ermis E; Leiser D; Zbinden M; Anschuetz L; Raabe A; Caversaccio M; Wiest R; Herrmann E Strahlenther Onkol; 2018 Dec; 194(12):1132-1143. PubMed ID: 30203112 [TBL] [Abstract][Full Text] [Related]
6. Inherent functional dependence among cochlear dose surrogates for stereotactic radiosurgery of vestibular schwannomas. Ma L; Braunstein SE; Theodosopoulos PV; McDermott MW; Sneed PK Pract Radiat Oncol; 2017; 7(1):e1-e7. PubMed ID: 27742557 [TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation. Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183 [TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2. Sun S; Liu A J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate. Linskey ME J Neurosurg; 2000 Dec; 93 Suppl 3():90-5. PubMed ID: 11143270 [TBL] [Abstract][Full Text] [Related]
19. Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Brown M; Ruckenstein M; Bigelow D; Judy K; Wilson V; Alonso-Basanta M; Lee JY Neurosurgery; 2011 Sep; 69(3):605-13; discussion 613-4. PubMed ID: 21471832 [TBL] [Abstract][Full Text] [Related]
20. Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. Thomas C; Di Maio S; Ma R; Vollans E; Chu C; Clark B; Lee R; McKenzie M; Martin M; Toyota B J Neurosurg; 2007 Nov; 107(5):917-26. PubMed ID: 17977261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]